Trial Profile
Efficacy and safety of post-operative Iloprost for the treatment of pulmonary hypertension in children undergoing surgery for the correction of congenital heart disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- 10 May 2016 New trial record